WikiMD is world's largest health encyclopedia with
28,590 pages, 3,998,516 edits & 34,519,754 views.
ATR kinase inhibitor AZD6738
An orally available morpholino-pyrimidine-based inhibitor of ataxia telangiectasia and rad3 related (ATR) kinase, with potential antineoplastic activity. Upon oral administration, ATR kinase inhibitor AZD6738 selectively inhibits ATR activity by blocking the downstream phosphorylation of the serine/threonine protein kinase CHK1. This prevents ATR-mediated signaling, and results in the inhibition of DNA damage checkpoint activation, disruption of DNA damage repair, and the induction of tumor cell apoptosis. In addition, AZD6738 sensitizes tumor cells to chemo- and radiotherapy. ATR, a serine/threonine protein kinase upregulated in a variety of cancer cell types, plays a key role in DNA repair, cell cycle progression, and survival; it is activated by DNA damage caused during DNA replication-associated stress.
Learn more about ATR kinase inhibitor AZD6738
Latest research (Pubmed)
External links
WikiMD needs you!
This WikiMD article ATR kinase inhibitor AZD6738 is a stub.
If you are a healthcare professional familiar with the topic ATR kinase inhibitor AZD6738, or
A subject matter expert or authority on ATR kinase inhibitor AZD6738, you can help us.
About | Mission | Paid editors welcome!
| ATR kinase inhibitor AZD6738 is part of WikiMD's Physician reviewed^ articles available 4free, 4all, 4ever! |
|---|
| Medicine: Health - Encyclopedia - Topics - Diseases - Cancer - Rare diseases - Random Page Navigation: Drugs - Wellness - Obesity - Diet - Ketogenic diet - W8MD weight loss diet - Editors: Recently Edited Pages - Alphabetical Order - Sponsors - USMLE The content on or accessible through WikiMD is for informational purposes only. WikiMD is not a substitute for professional medical advice. ^See full Disclaimers |
 Ad. Tired of being overweight?. W8MD's insurance Weight loss program can HELP* |
